eloralintide and tirzepatide for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Oct 2026: Trial started, NCT07881458
  2. 19 Oct 2026: Trial registered, NCT07881458

The trials

NCT07881458: A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

State
Under way
Phase
Phase 3
People
1,000 planned
Started
16 Oct 2026
Primary completion
Oct 2029
Arms
EloraTZP
Results
None posted
  1. 16 Oct 2026: Trial started
  2. 19 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.